Correlation Between Tata Consultancy and Kilitch Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tata Consultancy and Kilitch Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tata Consultancy and Kilitch Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tata Consultancy Services and Kilitch Drugs Limited, you can compare the effects of market volatilities on Tata Consultancy and Kilitch Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tata Consultancy with a short position of Kilitch Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tata Consultancy and Kilitch Drugs.

Diversification Opportunities for Tata Consultancy and Kilitch Drugs

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Tata and Kilitch is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Tata Consultancy Services and Kilitch Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kilitch Drugs Limited and Tata Consultancy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tata Consultancy Services are associated (or correlated) with Kilitch Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kilitch Drugs Limited has no effect on the direction of Tata Consultancy i.e., Tata Consultancy and Kilitch Drugs go up and down completely randomly.

Pair Corralation between Tata Consultancy and Kilitch Drugs

Assuming the 90 days trading horizon Tata Consultancy is expected to generate 2.2 times less return on investment than Kilitch Drugs. But when comparing it to its historical volatility, Tata Consultancy Services is 1.98 times less risky than Kilitch Drugs. It trades about 0.08 of its potential returns per unit of risk. Kilitch Drugs Limited is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  18,115  in Kilitch Drugs Limited on September 12, 2024 and sell it today you would earn a total of  14,365  from holding Kilitch Drugs Limited or generate 79.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.38%
ValuesDaily Returns

Tata Consultancy Services  vs.  Kilitch Drugs Limited

 Performance 
       Timeline  
Tata Consultancy Services 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tata Consultancy Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Tata Consultancy is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Kilitch Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Tata Consultancy and Kilitch Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tata Consultancy and Kilitch Drugs

The main advantage of trading using opposite Tata Consultancy and Kilitch Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tata Consultancy position performs unexpectedly, Kilitch Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kilitch Drugs will offset losses from the drop in Kilitch Drugs' long position.
The idea behind Tata Consultancy Services and Kilitch Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios